Evidence map›Paper›PMID 28667374›Full record

ArticleCellular and molecular neurobiology2018

Human Umbilical Cord Mesenchymal Stem Cells Protect Against SCA3 by Modulating the Level of 70 kD Heat Shock Protein.

Tan Li, Yi Liu, Linjie Yu, Jiamin Lao, Meijuan Zhang, Jiali Jin, Zhengjuan Lu, Zhuo Liu, Yun Xu

Open access · greenAbstract read
In one paragraph

Article in Cellular and molecular neurobiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Repeated Mesenchymal Stromal Cell Treatment Sustainably Alleviates Machado-Joseph Disease.Molecular therapy : the journal of the American Society of Gene Therapy · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Tan LiDepartment of Neurology, Affiliated Drum Tower Hospital of Nanjing University Medical School, 321 ZhongShan Road, Nanjing City, 210008, Jiangsu Province, People's Republic of China.
Yi LiuDepartment of Neurology, Affiliated Drum Tower Hospital of Nanjing University Medical School, 321 ZhongShan Road, Nanjing City, 210008, Jiangsu Province, People's Republic of China.
Linjie YuDepartment of Neurology, Affiliated Drum Tower Hospital of Nanjing University Medical School, 321 ZhongShan Road, Nanjing City, 210008, Jiangsu Province, People's Republic of China.
Jiamin LaoDepartment of Neurology, Affiliated Drum Tower Hospital of Nanjing University Medical School, 321 ZhongShan Road, Nanjing City, 210008, Jiangsu Province, People's Republic of China.
Meijuan ZhangDepartment of Neurology, Affiliated Drum Tower Hospital of Nanjing University Medical School, 321 ZhongShan Road, Nanjing City, 210008, Jiangsu Province, People's Republic of China.
Jiali JinDepartment of Neurology, Affiliated Drum Tower Hospital of Nanjing University Medical School, 321 ZhongShan Road, Nanjing City, 210008, Jiangsu Province, People's Republic of China.
Zhengjuan LuDepartment of Neurology, Affiliated Drum Tower Hospital of Nanjing University Medical School, 321 ZhongShan Road, Nanjing City, 210008, Jiangsu Province, People's Republic of China.
Zhuo LiuDepartment of Neurology, Affiliated Drum Tower Hospital of Nanjing University Medical School, 321 ZhongShan Road, Nanjing City, 210008, Jiangsu Province, People's Republic of China. aliceliuzhuo@163.com.ORCID http://orcid.org/0000-0002-1684-9004
Yun XuDepartment of Neurology, Affiliated Drum Tower Hospital of Nanjing University Medical School, 321 ZhongShan Road, Nanjing City, 210008, Jiangsu Province, People's Republic of China.
Nanjing Drum Tower Hospital · CN

Funding

National Natural Science Foundation of China 81200876National Natural Science Foundation of China 81230026National Natural Science Foundation of China 81300988National Natural Science Foundation of China 81501028science foundation from Jiangsu Provincial Commission of health and family planning H201538
6 · The paper itself

Abstract

Spinocerebellar ataxia 3 (SCA3), which is a progressive neurodegenerative disease, is currently incurable. Emerging studies have reported that human umbilical cord mesenchymal stem cells (HUC-MSCs) transplantation could be a promising therapeutic strategy for cerebellar ataxias. However, few studies have evaluated the effects of HUC-MSCs on SCA3 transgenic mouse. Thus, we investigated the effects of HUC-MSCs on SCA3 mice and the underlying mechanisms in this study. SCA3 transgenic mice received systematic administration of 2 × 10

Indexed as

Mesenchymal Stem Cell TransplantationAnimalsAtaxin-3Cell DifferentiationCells, CulturedCerebellumHSP70 Heat-Shock ProteinsHumansMesenchymal Stem CellsMice, TransgenicNerve Growth FactorsNeuronsProtective AgentsUmbilical CordAtaxin-3Atxn3 protein, mouseHSP70 Heat-Shock ProteinsNerve Growth FactorsProtective AgentsAtaxiaHSP70Human umbilical cord mesenchymal stem cellsNeurotrophinsPurkinje cellsSpinocerebellar ataxia 3

Identifiers

PMID28667374
PMCPMC11482022
OpenAlexW2725670137

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.